Amniotic Membrane Biopolymer for Regenerative Medicine. 2023

Evgeny Milyudin, and Larisa Teodorovna Volova, and Ksenia E Kuchuk, and Elena V Timchenko, and Pavel E Timchenko
Biotechnology Center "Biotech", Samara State Medical University, 443079 Samara, Russia.

Biopolymers based on the amniotic membrane compare favorably with synthetic materials in that, along with a specific 2D structure, they have biologically active properties. However, in recent years, there has been a tendency to perform decellularization of the biomaterial during the preparation of the scaffold. In this study, we studied the microstructure of 157 samples and identified individual biological components in the manufacture of a medical biopolymer from an amniotic membrane using various methods. Group 1 had 55 samples, and the amniotic membrane was impregnated with glycerol and dried over silica gel. Group 2 had 48 samples, and the decellularized amniotic membrane was impregnated with glycerol followed by lyophilization, Group 3 had 44 samples, and the decellularized amniotic membrane without pre-impregnation with glycerol was subjected to lyophilization. Decellularization was performed by treatment with a low-frequency ultrasound at a frequency of 24-40 kHz in an ultrasonic bath. A morphological study using a light microscope and a scanning electron microscope showed the preservation of the structure of the biomaterial and more complete decellularization in samples subjected to lyophilization without prior impregnation with glycerol. The study of the Raman spectroscopy lines of a biopolymer made from a lyophilized amniotic membrane without preliminary impregnation with glycerin showed significant differences in the intensity of the spectral lines of amides, glycogen, and proline. Additionally, in these samples, the spectral lines of Raman scattering the characteristic of glycerol were not visualized; therefore, only biological substances characteristic of the native amniotic membrane have been preserved.

UI MeSH Term Description Entries

Related Publications

Evgeny Milyudin, and Larisa Teodorovna Volova, and Ksenia E Kuchuk, and Elena V Timchenko, and Pavel E Timchenko
March 2009, Regenerative medicine,
Evgeny Milyudin, and Larisa Teodorovna Volova, and Ksenia E Kuchuk, and Elena V Timchenko, and Pavel E Timchenko
November 2022, BMJ open ophthalmology,
Evgeny Milyudin, and Larisa Teodorovna Volova, and Ksenia E Kuchuk, and Elena V Timchenko, and Pavel E Timchenko
December 2022, Life sciences,
Evgeny Milyudin, and Larisa Teodorovna Volova, and Ksenia E Kuchuk, and Elena V Timchenko, and Pavel E Timchenko
June 2010, Biotechnology letters,
Evgeny Milyudin, and Larisa Teodorovna Volova, and Ksenia E Kuchuk, and Elena V Timchenko, and Pavel E Timchenko
February 2022, Polymers,
Evgeny Milyudin, and Larisa Teodorovna Volova, and Ksenia E Kuchuk, and Elena V Timchenko, and Pavel E Timchenko
June 2016, Current stem cell reports,
Evgeny Milyudin, and Larisa Teodorovna Volova, and Ksenia E Kuchuk, and Elena V Timchenko, and Pavel E Timchenko
March 2011, Differentiation; research in biological diversity,
Evgeny Milyudin, and Larisa Teodorovna Volova, and Ksenia E Kuchuk, and Elena V Timchenko, and Pavel E Timchenko
March 2003, Nihon rinsho. Japanese journal of clinical medicine,
Evgeny Milyudin, and Larisa Teodorovna Volova, and Ksenia E Kuchuk, and Elena V Timchenko, and Pavel E Timchenko
October 2023, Materials today. Bio,
Evgeny Milyudin, and Larisa Teodorovna Volova, and Ksenia E Kuchuk, and Elena V Timchenko, and Pavel E Timchenko
June 2020, Current diabetes reports,
Copied contents to your clipboard!